These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27849134)

  • 1. Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.
    Nickho H; Younesi V; Aghebati-Maleki L; Motallebnezhad M; Majidi Zolbanin J; Movassagh Pour A; Yousefi M
    Bioengineered; 2017 Sep; 8(5):501-510. PubMed ID: 27849134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
    Zarei N; Fazeli M; Mohammadi M; Nejatollahi F
    Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of anti-proliferative and apoptotic effects by anti-IL-25 receptor single chain antibodies in breast cancer cells.
    Younesi V; Nejatollahi F
    Int Immunopharmacol; 2014 Dec; 23(2):624-32. PubMed ID: 25466271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
    Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.
    Motallebnezhad M; Younesi V; Aghebati-Maleki L; Nickho H; Safarzadeh E; Ahmadi M; Movassaghpour AA; Hosseini A; Yousefi M
    Tumour Biol; 2016 Nov; 37(11):14841-14850. PubMed ID: 27639384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of the scFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study.
    Khodaverdi E; Shabani AA; Madanchi H; Farahmand L
    Clin Transl Oncol; 2024 Jan; 26(1):231-238. PubMed ID: 37310573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
    Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
    Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
    Tohidkia MR; Asadi F; Barar J; Omidi Y
    BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
    Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
    Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique.
    Aghebati-Maleki L; Younesi V; Jadidi-Niaragh F; Baradaran B; Majidi J; Yousefi M
    Hum Antibodies; 2017; 25(1-2):57-63. PubMed ID: 28128766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies.
    Aghebati-Maleki L; Younesi V; Baradaran B; Abdolalizadeh J; Motallebnezhad M; Nickho H; Shanehbandi D; Majidi J; Yousefi M
    SLAS Discov; 2017 Apr; 22(4):408-417. PubMed ID: 28328317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology.
    Foroumadi S; Rajabibazl M; Rahimpour A; Shahidi S; Ebrahimizadeh W; Yarahmadi M; Rajabi S; Daraei A
    In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):85-91. PubMed ID: 29305748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
    Lei G; Xu M; Xu Z; Gu L; Lu C; Bai Z; Wang Y; Zhang Y; Hu H; Jiang Y; Zhao W; Tan S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FZD7 has a critical role in cell proliferation in triple negative breast cancer.
    Yang L; Wu X; Wang Y; Zhang K; Wu J; Yuan YC; Deng X; Chen L; Kim CC; Lau S; Somlo G; Yen Y
    Oncogene; 2011 Oct; 30(43):4437-46. PubMed ID: 21532620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study.
    Jalilzadeh-Razin S; Mantegi M; Tohidkia MR; Pazhang Y; Pourseif MM; Barar J; Omidi Y
    Daru; 2019 Jun; 27(1):21-34. PubMed ID: 30607886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies.
    Qamsari ES; Sharifzadeh Z; Bagheri S; Riazi-Rad F; Younesi V; Abolhassani M; Ghaderi SS; Baradaran B; Somi MH; Yousefi M
    J Immunotoxicol; 2017 Dec; 14(1):23-30. PubMed ID: 28090795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology.
    Abdolalizadeh J; Nouri M; Zolbanin JM; Barzegari A; Baradaran B; Barar J; Coukos G; Omidi Y
    Curr Pharm Des; 2013; 19(15):2839-47. PubMed ID: 23432628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-based subtractive panning strategy for selection of conformation-specific single-chain variable-fragment (scFv) against dimerization domain of EGFR.
    Valadan R; Dabiri M; Tehrani M; Hashemi Tabar G; Rafiei A
    J Immunol Methods; 2023 Apr; 515():113456. PubMed ID: 36898519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.